Definitive Contract HHSN263201500012C
- Not listed
- This federal contract award to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, is a firm fixed-price delivery order contract awarded by the Northeast Area of a civilian federal agency. The contract, which has a ceiling value of $165,447.00, is for a variety of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, and pharmacokinetics testing for various...
- This is a $1,974,948.75 definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America Holdings (LabCorp), a global life sciences company. The contract is for medical laboratory testing and analysis services, including clinical diagnostics, reference laboratory testing, genetic testing, and specialized medical analyses. The contract does not have a set-aside designation, indicating LabCorp competed in an open market procurement....
- This is a $159,285.00 firm fixed-price delivery order awarded by the Northeast Area of the U.S. Department of Civilian agencies to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract is for nutrient analysis of processed and prepared foods under the Nutrient Cluster B program. There is no set-aside designation. Labcorp Early Development Laboratories Inc. is a for-profit organization that provides analytical laboratory services...
- This is a definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $641,490.62, was awarded to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, a for-profit organization. The contract is for regulatory and support services related to the development of investigational new drugs. It is a firm...
- This is a federal contract award with ID V797P04FDF20026|V797S50002 for LAB SERVICES, awarded by the U.S. Air Force to Laboratory Corporation of America (LabCorp), a large for-profit clinical laboratory testing provider. The $54,190.31 firm fixed price delivery order contract does not have a set-aside designation and was awarded on December 8, 2005 with a completion date of September 30, 2006. LabCorp provides a variety of laboratory testing services to federal agencies including the National...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) to Laboratory Corporation of America (LabCorp) on March 10, 2016 with a ceiling value of $45,000.00. The contract was not set aside for any specific business type. Under this contract, LabCorp is providing laboratory testing services related to Congenital Adrenal Hyperplasia and other medical testing. LabCorp has also received subcontract awards from Leidos Biomedical Research Inc....
- This is a firm fixed-price delivery order contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Laboratory Corporation of America (LabCorp), a leading global life sciences company. The contract, valued at $208,412.50, is for laboratory testing services to support the National Naval Medical Center (NNMC). The contract does not have a set-aside designation. As a major provider of clinical laboratory services to federal...
- This $149,949.15 firm fixed price delivery order was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Laboratory Corporation of America for COVID-19 testing services for FDA employees and contractors. The contract has a period of performance through July 18, 2023 and no set-aside designation was used. As the largest commercial clinical laboratory network in the world, Laboratory Corporation of America will leverage its extensive experience and...
- This firm fixed-price purchase order for $115,542.49 was awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract is for the analysis of amino acids and was set aside for small businesses. Labcorp has a history of providing a range of specialized laboratory testing and analytical services to various federal agencies, including the National Institutes...
- This is a firm fixed-price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Laboratory Corporation of America (LabCorp), a global life sciences company that provides diagnostic information services. The contract is for $280,526.24 to provide clinical reference laboratory testing services. LabCorp has previously been awarded various federal contracts to provide medical laboratory testing and analysis services, including under its own GSA Federal...
This is a $5,273,743 firm fixed-price definitive contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The contract does not have a set-aside designation. Under this contract, Labcorp will provide a range of laboratory testing and analytical services to support the federal government, including stability testing, potency and safety assays for drug products, polyclonal antibody production, pharmacokinetics testing, compositional analysis, and long-term storage of cell line repositories for agencies like the National Institutes of Health, Food and Drug Administration, and National Institute of Neurological Disorders and Stroke. Laboratory Corporation of America Holdings, the parent company, has also provided serology testing services to the Centers for Disease Control and Prevention to aid in expanding coronavirus diagnostic testing capacity during the COVID-19 pandemic.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NEI Toxicity Studies to Support an IND Filing for Conducting Phase I Study of iPSC-Derived RPE on Scaffold | HHS-NIH-OD-PS-15-001 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 3/30/15, 10:51 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Close Out | $0 | 2/16/21 | |
| 3 | Exercise an Option | $2.4m | 6/19/17 | |
| 2 | Other Administrative Action | $500.0k | 9/23/16 | |
| 1 | Exercise an Option | $1.2m | 6/21/16 | |
| Not listed | Not listed | $1.2m | 9/28/15 |